SANOMUNE
Sanomune is a product based biopharmaceutical company oriented towards therapeutic regulation of the immune system.
Similar Organizations
Kupando
Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
More informations about "Sanomune"
Sanomune Company Profile 2024: Valuation, Investors ... - PitchBook
Sanomune General Information Description. Operator of a biotechnology company focused on developing treatments for neurological diseases. The company's lead compound, SAN-61 is a treatment for Alzheimer's disease that has demonstrated neural properties as well as the โฆSee details»
Sanomune - Crunchbase Company Profile & Funding
Sanomune is a product based biopharmaceutical company oriented towards therapeutic regulation of the immune system. Search Crunchbase. Start Free Trial . Chrome Extension. โฆSee details»
Sanomune Inc. - VentureRadar
Sanomune Inc. VentureRadar profile. Find out more about Sanomune Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Ardena โฆSee details»
Sanomune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Sanomune, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:SAN-61.See details»
Sanomune - Ownership and Business Overview - Mergr
Sanomune is a medical products company. Medical Products M&A Summary in 2010. Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2010. The โฆSee details»
Sanomune - Products, Competitors, Financials, Employees, โฆ
Sanomune's pipeline also includes products for rheumatoid arthritis (RA) multiple sclerosis (MS), stroke and diabetes. One patent has issued and six others have been filed. Sanomune is โฆSee details»
Sanomune - Drug pipelines, Patents, Clinical trials - Synapse
Last update 01 Nov 2024. Sanomune. Private CompanySee details»
Sanomune - Overview, News & Similar companies | ZoomInfo.com
Who is Sanomune. Sanomune is a private biotechnology company focused on developing treatments for neurological diseases. The company's lead compound, SAN-61, is a p romising โฆSee details»
Sanomune Inc - Company Profile and News - Bloomberg Markets
Sanomune Inc. is a biopharmaceutical company. The Company develops products for treatment of neurological and autoimmune disorders such as alzheimer's disease, rheumatoid arthritis, โฆSee details»
Sanomune - Crunchbase
Sanomune is a product based biopharmaceutical company oriented towards therapeutic regulation of the immune system.See details»
Sanomune Company Profile | Management and Employees List
Sanomune Profile and History. Sanomune is a private biotechnology company focused on developing treatments for neurological diseases. The company's lead compound, SAN-61, is a โฆSee details»
DiaMedica acquires Sanomune - 2010-06-30 - Crunchbase
Jun 30, 2010 Sanomune Sanomune is a product based biopharmaceutical company oriented towards therapeutic regulation of the immune system. Acquiring Organization: DiaMedica โฆSee details»
Sanomune Inc. - Winnipeg, Manitoba, Canada @ BiosciRegister.com
Profile: Sanomune Inc. is a biopharmaceutical company that offers products for the treatment of neurological and autoimmune disorders.Our product pipeline includes a repurposed biological โฆSee details»
Sanomune Inc. - BioCentury Company Profiles - BCIQ
Jul 5, 2010 Sanomune Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Sanomune Inc in Winnipeg, MB | 2044777590 | 411.ca
Learn more about Sanomune Inc | Winnipeg, MB. Find directions and contact info, read reviews and browse photos on their 411 business listing.See details»
SanoMune - 3 Competitors and alternatives in Oct 2024 - Tracxn
SanoMune has 3 active competitors. Competitors include Francfranc, Ganko Oyaji.See details»
Sanomune Inc. - Party | RPX Insight
Sanomune Inc. has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendant ... View as Organization Sanomune Inc. Related โฆSee details»
Research programme: autoimmune disorder therapeutics
Sanomune (a DiaMedica subsidiary) was undertaking a research programme to develop repurposed recombinant protein products using its immunomodulation technologySee details»
Deferoxamine intranasal - Sanomune - AdisInsight
30 Jun 2010 Sanomune has been acquired by DiaMedica 06 Mar 2009 Preclinical trials in Alzheimer's disease in USA (Intranasal) You need to be a logged in or subscribed to view this โฆSee details»
Sano Tsunetami - Wikipedia
Sano was born in Hayatsue, Saga Domain (present-day Saga city, Saga Prefecture) as the fifth son of the low ranking samurai Shimomura Saburลzaemon. In 1831 he was adopted by the โฆSee details»